Imbeba irwanya SARS-COV-2 NP antibody ya monoclonal

Intangiriro

IsukuProteine ​​A / G inkingi yinkingiIsotypeIgG1 kappaHost Ubwoko bwimbebaSpecies ReactivityHumanApplicationImmunochromatography (IC) / Chemiluminescent Immunoassay (CLIA)

Ibisobanuro birambuye

Ibicuruzwa

Ibisobanuro birambuye

Amakuru rusange
SARS-CoV-2.Ni karonavirusi ya karindwi izwi kwanduza abantu nyuma ya 229E, NL63, OC43, HKU1, MERS-CoV, na SARS-CoV y'umwimerere.

Ibyiza

Icyifuzo CLIA (Gufata-Kumenya): 9-1 ~ 81-4
Isuku > 95% nkuko byagenwe na SDS-PAGE.
Buffer PBS, pH7.4.
Ububiko Ubike mubihe bidasanzwe kuri -20 ℃ kugeza -80 ℃ umaze kwakira.Kububiko bwigihe kirekire, nyamuneka aliquot uyibike.Irinde gukonjesha inshuro nyinshi.

Tegeka amakuru

izina RY'IGICURUZWA Injangwe.Oya Indangamuntu ya Clone
SARS-COV-2 NP AB0046-1 9-1
AB0046-2 81-4
AB0046-3 67-5
AB0046-4 54-7

Icyitonderwa: irashobora guhitamo ingano kubyo ukeneye.

Isesengura ryo kugereranya

Imirongo

1.Coronaviridae Itsinda ryiga rya komite mpuzamahanga ishinzwe imisoro ya virusi.Ubwoko bukabije syndrome yubuhumekero bukabije bujyanye na coronavirus: gushyira 2019-nCoV no kuyita SARS-CoV-2.Nat.Microbiol.5, 536–544 (2020)
2.Fehr, AR & Perlman, S. Coronaviruses: incamake yo kwigana kwabo no gutera indwara.Uburyo.Mol.Biol.1282, 1-23 (2015).
3.Shang, J. n'abandi.Ishingiro ryuburyo bwo kumenyekanisha reseptor na SARS-CoV-2.Kamere https://doi.org/10.1038/ s41586-020-2179-y (2020).


  • Mbere:
  • Ibikurikira:

  • Andika ubutumwa bwawe hano hanyuma utwohereze

    Inzobere mu bya tekinike yabigize umwuga yitangiye kukuyobora

    Ukurikije ibyo ukeneye mubyukuri, hitamo uburyo bushyize mu gaciro bwo gutegura no gutegura